News
05-24-2023, 12:27 PM
The Mays Cancer Center at The University of Texas Health Science Center at San Antonio recently conducted a clinical trial combining two drugs in patients with recurrent, high-grade glioblastoma (GBM).
More... (https://www.news-medical.net/news/20230524/Mays-Cancer-Center-conducts-clinical-trial-combining-two-drugs-in-patients-with-recurrent-high-grade-glioblastoma.aspx)
More... (https://www.news-medical.net/news/20230524/Mays-Cancer-Center-conducts-clinical-trial-combining-two-drugs-in-patients-with-recurrent-high-grade-glioblastoma.aspx)